EP2049143 - IMPROVED ANTIBACTERIAL ANTISENSE OLIGONUCLEOTIDE AND METHOD [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 10.01.2014 Database last updated on 24.08.2024 | Most recent event Tooltip | 10.01.2014 | Application deemed to be withdrawn | published on 12.02.2014 [2014/07] | Applicant(s) | For all designated states AVI BioPharma, Inc. Suite 200, 4575 S.W. Research Way Corvallis, OR 97333 / US | [2009/17] | Inventor(s) | 01 /
WELLER, Dwight, D. 3323 N.W. Elmwood Drive Corvallis, OR 97330 / US | 02 /
GELLER, Bruce, L. 6994 N.W. Concord Drive Corvallis, OR 97330 / US | 03 /
IVERSEN, Patrick, L. 5902 N.W. Fair Oaks Place Corvallis, OR 97333 / US | 04 /
TILLEY, Lucas, D. 36 Little Eagle Boy Burlington, VT 05408 / US | 05 /
HASSINGER, Jed, N. 24319 Price Creek Road Philomath, OR 97370 / US | [2009/23] |
Former [2009/17] | 01 /
WELLER, Dwight, D. 3323 N.W. Elmwood Drive Corvallis, OR 97330 / US | ||
02 /
GELLER, Bruce, L. 6994 N.W. Concord Drive Corvallis, OR 97330 / US | |||
03 /
IVERSEN, Patrick, L. 5902 N.W. Fair Oaks Place Corvallis, OR 97333 / US | |||
04 /
TILLEY, Lucas, D. 36 Little Eagle Bay Burlingame, VT 05408 / US | |||
05 /
HASSINGER, Jed, N. 24319 Price Creek Road Philomath, OR 97370 / US | Representative(s) | Schiweck Weinzierl Koch Patentanwälte Partnerschaft mbB Ganghoferstraße 68 B 80339 München / DE | [N/P] |
Former [2011/42] | Schiweck, Weinzierl & Koch European Patent Attorneys Landsberger Straße 98 80339 München / DE | ||
Former [2009/17] | Barth, Renate, et al Vossius & Partner Siebertstrasse 4 81675 München / DE | Application number, filing date | 07794801.6 | 11.05.2007 | [2009/17] | WO2007US11431 | Priority number, date | US20060487009 | 13.07.2006 Original published format: US 487009 | [2009/17] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2008008113 | Date: | 17.01.2008 | Language: | EN | [2008/03] | Type: | A1 Application with search report | No.: | EP2049143 | Date: | 22.04.2009 | Language: | EN | The application published by WIPO in one of the EPO official languages on 17.01.2008 takes the place of the publication of the European patent application. | [2009/17] | Search report(s) | International search report - published on: | US | 17.01.2008 | (Supplementary) European search report - dispatched on: | EP | 18.10.2010 | Classification | IPC: | C12N15/11, A61K38/16, A61K31/70, A61K31/675 | [2010/46] | CPC: |
A61K48/00 (EP,US);
A61P31/04 (EP);
C12N15/111 (EP,US);
C12N15/113 (EP,US);
C12N2310/11 (EP,US);
C12N2310/3233 (EP,US);
|
Former IPC [2009/17] | A61K38/16, A61K31/70, A61K31/675 | Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, PL, PT, RO, SE, SI, SK, TR [2009/17] | Title | German: | VERBESSERTES ANTIBAKTERIELLES ANTISENSE-OLIGONUKLEOTID UND VERFAHREN | [2009/17] | English: | IMPROVED ANTIBACTERIAL ANTISENSE OLIGONUCLEOTIDE AND METHOD | [2009/17] | French: | OLIGONUCLÉOTIDE ANTISENS ANTIBACTÉRIEN AMÉLIORÉ ET PROCÉDÉ | [2009/17] | Entry into regional phase | 13.02.2009 | National basic fee paid | 13.02.2009 | Search fee paid | 13.02.2009 | Designation fee(s) paid | 13.02.2009 | Examination fee paid | Examination procedure | 13.02.2009 | Examination requested [2009/17] | 13.05.2011 | Amendment by applicant (claims and/or description) | 21.06.2011 | Despatch of a communication from the examining division (Time limit: M06) | 02.01.2012 | Reply to a communication from the examining division | 13.03.2012 | Despatch of a communication from the examining division (Time limit: M06) | 21.09.2012 | Reply to a communication from the examining division | 12.02.2013 | Despatch of a communication from the examining division (Time limit: M06) | 23.08.2013 | Application deemed to be withdrawn, date of legal effect [2014/07] | 24.09.2013 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2014/07] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 21.06.2011 | Fees paid | Renewal fee | 13.02.2009 | Renewal fee patent year 03 | 25.05.2010 | Renewal fee patent year 04 | 25.05.2011 | Renewal fee patent year 05 | 25.05.2012 | Renewal fee patent year 06 | 28.05.2013 | Renewal fee patent year 07 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]WO2004097017 (AVI BIOPHARMA INC [US], et al) [A] 1-15 * the whole document *; | [A]WO2006050414 (AVI BIOPHARMA INC [US], et al) [A] 1-15 * example 3 *; | [XP]WO2007009094 (AVI BIOPHARMA INC [US], et al) [XP] 1-15 * the whole document *; | [A] - GELLER B L ET AL, "Inhibition of gene expression in Escherichia coli by antisense phosphorodiamidate morpholino oligomers", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, AMERICAN SOCIETY FOR MICROBIOLOGY, WASHINGTON, DC, US LNKD- DOI:10.1128/AAC.47.10.3233-3239.2003, (20031001), vol. 47, no. 10, ISSN 0066-4804, pages 3233 - 3239, XP002402831 [A] 1-15 * table 2 * DOI: http://dx.doi.org/10.1128/AAC.47.10.3233-3239.2003 | [A] - DEERE JESSE ET AL, "Antisense phosphorodiamidate morpholino oligomer length and target position effects on gene-specific inhibition in Escherichia coli", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, AMERICAN SOCIETY FOR MICROBIOLOGY, WASHINGTON, DC, US LNKD- DOI:10.1128/AAC.49.1.249-255.2005, (20050101), vol. 49, no. 1, ISSN 0066-4804, pages 249 - 255, XP002402833 [A] 1-15 * table 1 * DOI: http://dx.doi.org/10.1128/AAC.49.1.249-255.2005 | [A] - GELLER B L ET AL, "Antisense Phosphorodiamidate Morpholino Oligomer Inhibits Viability of Escherichia coli in Pure Culture and in Mouse Peritonitis", JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, OXFORD UNIVERSITY PRESS, GB LNKD- DOI:10.1093/JAC/DKI129, (20050504), vol. 55, ISSN 0305-7453, pages 983 - 988, XP003008448 [A] 1-15 * page 984, column l; figure 1 * DOI: http://dx.doi.org/10.1093/jac/dki129 | [A] - NELSON MICHELLE H ET AL, "Arginine-rich peptide conjugation to morpholino oligomers: effects on antisense activity and specificity", BIOCONJUGATE CHEMISTRY, ACS, WASHINGTON, DC, US LNKD- DOI:10.1021/BC0501045, (20050701), vol. 16, no. 4, ISSN 1043-1802, pages 959 - 966, XP002543913 [A] 1-15 * table 1 * DOI: http://dx.doi.org/10.1021/bc0501045 | [A] - MOULTON H M ET AL, "CELLULAR UPTAKE OF ANTISENSE MORPHOLINO OLIGOMERS CONJUGATED TO ARGININE-RICH PEPTIDES", BIOCONJUGATE CHEMISTRY, ACS, WASHINGTON, DC, US LNKD- DOI:10.1021/BC034221G, (20040101), vol. 15, no. 2, ISSN 1043-1802, pages 290 - 299, XP002999956 [A] 1-15 * page 291, column l; table 1 * DOI: http://dx.doi.org/10.1021/bc034221g | [XP] - TILLEY L D ET AL, "Gene-Specific Effects of Antisense Phosphorodiamidate Morpholino Oligomer-peptide Conjugates on Eschericia coli and Salmonella enterica Serovar Typhimurium in Pure Culture and in Tissue Culture", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, AMERICAN SOCIETY FOR MICROBIOLOGY, WASHINGTON, DC, US LNKD- DOI:10.1128/AAC.01286-05, (20060801), vol. 50, no. 8, ISSN 0066-4804, pages 2789 - 2796, XP003008447 [XP] 1-15 * figures 4-6 * DOI: http://dx.doi.org/10.1128/AAC.01286-05 | International search | [X]US2006148747 (STEIN DAVID A [US], et al); | [Y]US7049431 (IVERSEN PATRICK L [US]); | [A]US6548651 (NIELSEN PETER E [DK], et al) | Examination | - Derek S. Youngblood ET AL, "Stability of Cell-Penetrating Peptide-Morpholino Oligomer Conjugates in Human Serum and in Cells", Bioconjugate Chemistry, (20070101), vol. 18, no. 1, doi:10.1021/bc060138s, ISSN 1043-1802, pages 50 - 60, XP055031622 DOI: http://dx.doi.org/10.1021/bc060138s |